A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond
一项随机 II 期研究,评估 SM-88 联合甲氧沙林、苯妥英钠和西罗莫司治疗二线及以上转移性胰腺癌患者的疗效。
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.4768
Noel, Marcus S; Kim, Semmie; Hartley, Marion L; Wong, Steve; Picozzi, Vincent J; Staszewski, Harry; Kim, Dae Won; Van Tornout, Jan M; Philip, Philip Agop; Chung, Vincent; Ocean, Allyson J; Wang-Gillam, Andrea